Vitamin D Deficiency: The Number One Cause For Shorter Lifespan?

90% of Black and Brown-Skinned People In America Are Vitamin D Deficient!

Recent Studies revealed, from a systematic review and meta-analysis of 75 observational studies and 30 RCTs, revealed that low vitamin D levels were associated with an increased risk of all-cause mortality including cancer, Diabetes, Heart Failure and High Blood Pressure.

When vitamin D levels are normal, these processes will operate to drive healthy ageing that occurs at a slower rate for melanated peoples (Tuohimaa, 2009; Haussler et al. 2010). However, when vitamin D is deficient these ageing processes will be enhanced and this will result in an increase in the rate of ageing. It is estimated that 30-50% of the world population is vitamin D deficient, and its incidence is increasing in the African American population as well as 40-80% of the elderly population who exhibit Vitamin D deficiency.

The frequency of vitamin D deficiency increases in both populations due to poor exposure to sunlight and decreased skin synthesis of the conversion of 7 dehydrocholesterol to previtamin D. Ironically the increase in UV radiation is countering that as it simultaneously causes a rise in skin cancer rates and infertility among populations without Eumelanin. In addition, it has been observed that vitamin D deficiency is very common in 80% to 95% of the Asian population. The prevalence of vitamin D deficiency increases with age, and this appears to be associated with poor outcome in the elderly.

Vitamin D insufficiency impairs skeletal mineralization and bone growth rate during childhood, thus affecting height and health meaning children with this deficiency are prone to grow to shorter stature than others. School aged children 7~12 years old and adolescents 13~18 years old should recieve vitamin D supplementation in the form of childrens vitamins like flintstones chewables or gummy vitamins for optimum health. Overall health metrics for children not rcieving supplements in a control group studywere significantly lower compared with those of healthy vitamin controls. By contrast, C3-epi levels and C3-epi/25(OH)D3 ratios in all the three short-stature subgroups were markedly higher than the corresponding healthy cases. Based on cutoff values developed by Endocrine Society Recommendation When vitamin D supplements are helpful 1,000 to 1,500 IU a day for infants · 2,500 to 3,000 IU a day for children 1 to 8 years old!

Getting enough vitamin D is essential so kids’ bones can grow strong and their immune systems can ward off illness. Vitamin D gets into the body through absorption of sunlight and ingestion of food. From April through the end of October, spending just 15 to 30 minutes outside in the middle of the day with hands and face exposed will not stimulate the skin of a child of color to make all the vitamin D your child needs. Foods such as salmon, sardines, tuna, cod liver oil, egg yolks and shiitake mushrooms contain a lot of vitamin D. Many kids don’t seem to love these vitamin D superfoods, so even though store-bought milk is often fortified with vitamin D it is not the healthiest choice for Black children who may be lactose intolerant nut milks like coconut and almond milk blends are a good option,but not all alternative milk products are fortified with vitamin D, so make sure to read the labels.

Most over-the-counter children’s vitamins contain 600 IU of vitamin D, which is the recommended daily allowance set by the U.S. Food and Drug Administration for kids 1 year old to 6 years old.

Children who are obese, who have dark skin, have specific medical conditions like celiac disease live in the arctic or who rarely go outside or who wear clothing that covers most of their skin may need supplements to ensure they have adequate levels of vitamin D all year round.

Some medications, such as anticonvulsants, as well as over-the-counter health aids like St. John’s Wort, can interfere with the way our bodies metabolize vitamin D. Certain conditions, such as celiac disease, can also interfere with absorption of vitamin D. Discuss your child’s medical history and lifestyle with your pediatrician, and make sure to them about any medicine or herbal supplements your child takes. If your child has specific conditions that hinder D absorption your pediatrician can then determine your child’s daily vitamin D requirement.

Across the board, African-American adults are generally at greater risk for a number of chronic and potentially life-shortening conditions such as hypertension, stroke, insulin resistance, metabolic syndrome, type 2 diabetes, cancer, heart disease and all-cause mortality, ALL of which is associated with vitamin D deficiency! When vitamin D levels are low and the body isn't able to properly absorb calcium and phosphorus, there is an increased risk of bone pain, bone fractures, muscle pain and muscle weakness. In older adults, severe vitamin D deficiency (levels less than 10 ng/mL in the blood), may also contribute to an increased risk of falls.

Human data studies my several major drug companies recently redacted by a whistleblower revealed that higher intake of fish or fish oil like cod liver oil may add years to lifespan. Human supplementation showed that EPA and DHA supplementation increased lifespan by 15%. That percentage calculated in years applied to humans would mean 12 years additional lifespan.

In 1979, the FDA ban on the interstate sale of laetrile (an effective anti cancer medicine) was upheld by the U.S. Supreme Court, effectively ending the common use of it. It has been classified by the cancer establishment as a classic case of “quackery,” meaning that those who claim it has anti-cancer properties are frauds. Thus, this case study shows how easily information about potentially effective cancer treatments can be suppressed by a handful of people in positions of authority. What they didnt discuss is that the addition of vitamin D to the average persons diet can lower the chances they will get skin cancer in a lifetime by 50% but has little effect on stomach cancer directly as a cure! In the case of Stomach Cancers Vitamin D supplementation was seen to indirectly prevent cancer. Patients that failed treatment to eradicate Helicobacter pylori, which is associated with gastric cancer, had a higher prevalence of Vitamin D deficiency than those that were successfully treated so it is wise to begin D supplementation before opting for this treatment according to data studies.

Higher vitamin D levels have been consistently associated with reduced risks of colorectal cancer and, to a lesser extent, bladder cancer. Studies have shown no association between vitamin D levels and risk of breast cancer but women with breast cancer that were deficient in Vitamin D had larger tumors, more advanced stage cancers and reduced survival than those that were not deficient! Vitamin D helps the body to absorb Calcium, which is essential for healthy and strong bones. It also encourages normal cell growth, boosts the immune system, and reduces inflammation in the body. It goes a long way in keeping you healthy and fighting off foreign bodies and illness.

Note: Taking Vitamin D for long periods of time in doses higher than your reccomended age requirement or for adults 4000 IU (100 mcg) daily it may cause very high levels of calcium in the blood. So it is wise to get enough Magnesium (lacking in most modern diets Magnesium reduced calcium and phosphate fractions by 68% and 41% extracellular crystals, respectively, without affecting the fraction of magnesium. A study (Boskey,Posner 1974) demonstrated that magnesium inhibits hydroxyapatite formation in the extracellular space, thereby preventing calcification of vascular smooth muscle cells. ) and vitamin K2 in your diet (Vitamin K2 promotes arterial flexibility by preventing accumulation of arterial calcium) from fresh green vegetables and check with your doctor annually if taking doses above

Sources

1. Cattaruzza MS, Pisani D, Fidanza L, Gandini S, Marmo G, Narcisi A, Bartolazzi A and Carlesimo M 2018, Eur. J. Cancer Prev, Epub 2018/02/14. [Google Scholar]

2. Heidari Z, Nikbakht M, Mashhadi MA, Jahantigh M, Mansoumia N, Sheikhi V and Mansoumia MA 2017, Asian Pac. J. Cancer Prev, 18, 3419–3422. [PMC free article] [PubMed] [Google Scholar]

3. Ismail A, El-Awady R, Mohamed G, Hussein M and Ramadan SS 2018, Asian Pac. J. Cancer Prev, 19, 571–576. [PMC free article] [PubMed] [Google Scholar]

4. Takahashi H, Cornish AJ, Sud A, Law PJ, Kinnersley B, Ostrom QT, Labreche K, Eckel-Passow JE, Armstrong GN, Claus EB, Ll’yasova D, Schildkraut J, Bamholtz-Sloan JS, Olson SH, Bernstein JL, Lai RK, Schoemaker MJ, Simon M, Hoffmann P, Nothen MM, Jockel KH, Chanock S, Rajaraman P, Johansen C, Jenkins RB, Melin BS, Wrensch MR, Sanson M, Bondy ML, Turnbull C and Houlston RS 2018, Sci. Rep, 8, 2339. [PMC free article] [PubMed] [Google Scholar]

5. O’Sullivan F, van Geffen J, van Weele M and Zgaga L 2018, Photochem. Photobiol, 94, 797–806. [PubMed] [Google Scholar]

6. Budhathoki S, Hidaka A, Yamaji T, Sawada N, Tanaka-Mizuno S, Kuchiba A, Charvat H, Goto A, Kojima S, Sudo N, Shimazu T, Sasazuki S, Inoue M, Tsugane S and Iwasaki M 2018, B.M.J, 360, k671. [PMC free article] [PubMed] [Google Scholar]

7. Yildirim O, Yildirim T, Seckin Y, Osanmaz P, Bilgic Y and Mete R 2017, Adv. Clin. Exp. Med, 26, 1377–1381. [PubMed] [Google Scholar]

8. Xie DD, Chen YH, Xu S, Zhang C, Wang DM, Wang H, Chen L, Zhang ZH, Xia MZ, Xu DX and Yu DX 2017, Oncotarget, 8, 22076–22085. [PMC free article] [PubMed] [Google Scholar]

9. Vayrynen JP, Mutt SJ, Herzig KH, Vayrynen SA, Kantola T, Karhu T, Karttunen TJ, Klintrup K, Makela J, Makinen MJ and Tuomisto A 2016, Sci. Rep, 6,36519. [PMC free article] [PubMed] [Google Scholar]

10. Liu Y, Wang X, Sun X, Lu S and Liu S 2018, Medicine, 97, e0114. [PMC free article] [PubMed] [Google Scholar]

11. Feng Q, Zhang H, Dong Z, Zhou Y and Ma J 2017, Medicine, 96, e8613. [PMC free article] [PubMed] [Google Scholar]

12. Hu MJ, Zhang Q, Liang L, Wang SY, Zheng XC, Zhou MM, Yang YW, Zhong Q and Huang F 2018, J. Endocrinol. Invest, Epub 2018/02/22. [Google Scholar]

13. Liu J, Dong Y, Lu C, Wang Y, Peng L, Jiang M, Tang Y and Zhao Q 2017, Oncotarget, 8, 81040–81051. [PMC free article] [PubMed] [Google Scholar]

14. Supnick HT, Bunaciu RP and Yen A 2018, Oncotarget, 9, 9808–9824. [PMC free article] [PubMed] [Google Scholar]

15. Djurasinovic VT, Mihaljevic BS, Sipetic Grujicic SB, Ignjatovic SD, Trajkovic G, Todorovic-Balint MR, Antic DA, Bila JS, Andjelic BM, Jelicic JJ, Vukovic VM, Nikolic AM and Klek S 2018, Support. Care Cancer, 26,2825–2832. [PubMed] [Google Scholar]

16. Seyedalipour F, Mansouri A, Vaezi M, Gholami K, Heidari K, Hadjibabaie M and Ghavamzadeh A 2017, Int. J. Hematol. Oncol. Stem Cell Res, 11, 209–216. [PMC free article] [PubMed] [Google Scholar]

17. Cheney CP, Thorand B, Huth C, Berger K, Peters A, Seifert-Klauss V, Kiechle M, Strauch K and Quante AS 2018, Oncol. Res. Treat, 41, 117–121. [PubMed] [Google Scholar]

18. van Duijnhoven FJB, Jenab M, Hveem K, Siersema PD, Fedirko V, Duell EJ, Kampman E, Halfweeg A, van Kranen HJ, van den Ouweland JMW, Weiderpass E, Murphy N, Langhammer A, Ness-Jensen E, Olsen A, Tjonneland A, Overvad K, Cadeau C, Kvaskoff M, Boutron-Ruault MC, Katzke VA, Kuhn T, Boeing H, Trichopoulou A, Kotanidou A, Kritikou M, Palli D, Agnoli C, Tumino R, Panico S, Matullo G, Peeters P, Brustad M, Olsen KS, Lasheras C, Obon-Santacana M, Sanchez MJ, Dorronsoro M, Chirlaque MD, Barricarte A, Manjer J, Almquist M, Renstrom F, Ye W, Wareham N, Khaw KT, Bradbury KE, Freisling H, Aune D, Norat T, Riboli E and Buenode-Mesquita HBA 2018, Int. J. Cancer, 142, 1189–1201. [PMC free article] [PubMed] [Google Scholar]

19. Muller DC, Hodge AM, Fanidi A, Albanes D, Mai XM, Shu XO, Weinstein SJ, Larose TL, Zhang X, Han J, Stampfer MJ, Smith-Wamer SA, Ma J, Gaziano JM, Sesso HD, Stevens VL, McCullough ML, Layne TM, Prentice R, Pettinger M, Thomson CA, Zheng W, Gao YT, Rothman N, Xiang YB, Cai H, Wang R, Yuan JM, Koh WP, Butler LM, Cai Q, Blot WJ, Wu J, Ueland PM, Midttun O, Langhammer A, Hveem K, Johansson M, Hultdin J, Grankvist K, Arslan AA, Le Marchand L, Severi G, Johansson M and Brennan P 2018, Ann. Oncol, 29, 1468–1475. [PMC free article] [PubMed] [Google Scholar]

20. Bryce C 2018, Mil. Med, 183, 547–551. [PubMed] [Google Scholar]

21. Gao J, Wei W, Wang G, Zhou H, Fu Y and Liu N 2018, Ther. Clin. Risk Manag, 14, 95–104. [PMC free article] [PubMed] [Google Scholar]

22. Bao Y, Zhang S, Guo Y, Wei X, Zhang Y, Yang Y, Zhang H, Ma M and Yang W 2018, Clin. Transl. Oncol, 2018/02/10. [PubMed] [Google Scholar]

23.Boskey AL, Posner AS. Magnesium stabilization of amorphous calcium phosphate: A kinetic study. Mater Res Bull. 1974;9:907–916. doi: 10.1016/0025-5408(74)90169-X.